XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Option Plan (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity Stock option activity under the Company's 2019 Plan is set forth below: 
Number of
Options
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 20212,014,330 $12.10 7.87$5,428 
Granted63,000 $5.25 
Exercised(1,273)$0.33 
Forfeited(114,182)$13.74 
Expired(141,320)$13.79 
Outstanding, September 30, 2022
1,820,555 $11.63 7.19$1,150 
Vested and expected to vest, September 30, 2022
1,820,555 $11.63 7.19$1,150 
Options exercisable, September 30, 2022
1,321,485 $10.59 6.93$1,126 
Schedule of Restricted Stock Unit Activity
Restricted stock unit activity under the Company's 2019 Plan is set forth below:
Number of
Shares
Weighted-
Average
Grant Date Fair Value
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 2021415,325 $16.54 $4,830 
Awards granted604,100 $8.61 
Awards released(99,624)$16.62 
Awards canceled(114,305)$11.72 
Outstanding, September 30, 2022
805,496 $11.27 $2,183 
Schedule of Fair Value Assumptions, Stock Options
The fair value of employee stock options was estimated using the following assumptions to determine the fair value of stock options granted:
 
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Expected volatility
—%
86%
54%
83%-86%
Risk-free interest rate
—%
0.9%
3.4%
0.8%-1.1%
Dividend yield
Expected term (in years)
0
5.77
5.5
5.50-6.08
Schedule of Fair Value Assumptions, Employee Stock Purchase Plan The following assumptions were used to calculate the stock-based compensation for each stock purchase right granted under the ESPP:
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Expected volatility45%45%
45%-57%
45%-60%
Risk-free interest rate0.6%0.1%
0.6%-3.3%
0.1%
Dividend yield
Expected term (in years)0.500.500.500.50
Schedule of Non-cash Stock-based Compensation Expense
Total non-cash stock-based compensation expense recorded related to options granted, restricted stock units granted and stock purchase rights granted under the ESPP in the condensed statements of operations is as follows (in thousands):
 
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Costs of revenue$56 $64 $159 $136 
Selling, general and administrative1,085 1,115 3,406 2,955 
Research and development165 175 557 460 
Total$1,306 $1,354 $4,122 $3,551